TAK-272
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TAK-272, covering 2016-05-23 to 2018-08-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria [Phase 2]